Brief: Cyclerion Therapeutics Announces Progress Toward Cyc-126 Phase 2 Proof-Of-Concept Study With FDA Feedback
17/02/2026 12:28
Feb 17 (Reuters) - Cyclerion Therapeutics Inc CYCN.O: CYCLERION THERAPEUTICS ANNOUNCES PROGRESS TOWARD CYC-126 PHASE 2 PROOF-OF-CONCEPT STUDY WITH FDA FEEDBACK AND FORMATION OF CLINICAL ADVISORY BOARD CYCLERION THERAPEUTICS INC - ON TRACK TO INITIATE PHASE 2 STUDY IN 2026 Source text: ID:nGNX4Jz68W Further company coverage: CYCN.O ((Reuters.Briefs@thomsonreuters.com;))